Evidence map›Paper›PMID 27414076›Full record

ReviewThe Clinical neuropsychologist2016

Fragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders.

Erin E Robertson, Deborah A Hall, Andrew R McAsey, Joan A O'Keefe

Open access · greenAbstract readCase ReportsComparative StudyReview
In one paragraph

Review in The Clinical neuropsychologist, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Neurodegeneration of White and Gray Matter in the Hippocampus with FXTAS.International journal of molecular sciences · 2023
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Neuropathology ofBrain communications · 2021
    Article
  12. Prodromal Markers of Upper Limb Deficits inMovement disorders clinical practice · 2020
    Article
  13. Review
  14. Aging with Autism Departs Greatly from Typical Aging.Sensors (Basel, Switzerland) · 2020
    Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Erin E Robertsona Department of Anatomy and Cell Biology , Rush University , Chicago , IL , USA.
Deborah A Hallb Department of Neurological Sciences , Rush University , Chicago , IL , USA.
Andrew R McAseya Department of Anatomy and Cell Biology , Rush University , Chicago , IL , USA.
Joan A O'Keefea Department of Anatomy and Cell Biology , Rush University , Chicago , IL , USA.
Rush University · US

Funding

Adult Neurological Phenotypes of Fragile X Gray Zone ExpansionR01NS082416 · NINDS · RUSH UNIVERSITY MEDICAL CENTER · PI HALL, DEBORAH A · 2013 to 2016
$1.2M
Impact of Cognitive function on Balance and Gait Markers for FXTASK01HD088762 · NICHD · RUSH UNIVERSITY MEDICAL CENTER · PI O'KEEFE, JOAN A · 2016 to 2021
$711k
NICHD NIH HHS K01 HD088762NINDS NIH HHS R01 NS082416
6 · The paper itself

Abstract

objectiveThe purpose of this paper is to review the typical cognitive and motor impairments seen in fragile X-associated tremor/ataxia syndrome (FXTAS), essential tremor (ET), Parkinson disease (PD), spinocerebellar ataxias (SCAs), multiple system atrophy (MSA), and progressive supranuclear palsy (PSP) in order to enhance diagnosis of FXTAS patients.

methodsWe compared the cognitive and motor phenotypes of FXTAS with each of these other movement disorders. Relevant neuropathological and neuroimaging findings are also reviewed. Finally, we describe the differences in age of onset, disease severity, progression rates, and average lifespan in FXTAS compared to ET, PD, SCAs, MSA, and PSP. We conclude with a flow chart algorithm to guide the clinician in the differential diagnosis of FXTAS.

resultsBy comparing the cognitive and motor phenotypes of FXTAS with the phenotypes of ET, PD, SCAs, MSA, and PSP we have clarified potential symptom overlap while elucidating factors that make these disorders unique from one another. In summary, the clinician should consider a FXTAS diagnosis and testing for the Fragile X mental retardation 1 (FMR1) gene premutation if a patient over the age of 50 (1) presents with cerebellar ataxia and/or intention tremor with mild parkinsonism, (2) has the middle cerebellar peduncle (MCP) sign, global cerebellar and cerebral atrophy, and/or subcortical white matter lesions on MRI, or (3) has a family history of fragile X related disorders, intellectual disability, autism, premature ovarian failure and has neurological signs consistent with FXTAS. Peripheral neuropathy, executive function deficits, anxiety, or depression are supportive of the diagnosis.

conclusionsDistinct profiles in the cognitive and motor domains between these movement disorders may guide practitioners in the differential diagnosis process and ultimately lead to better medical management of FXTAS patients.

Indexed as

PhenotypeAgedAtaxiaDisease ProgressionFemaleFragile X Messenger Ribonucleoprotein 1Fragile X SyndromeHumansMagnetic Resonance ImagingMaleMiddle AgedMovement DisordersNeuroimagingNeuropsychological TestsParkinson DiseaseTremorFragile X Messenger Ribonucleoprotein 1essential tremorFXTASmultiple system atrophyParkinson diseaseprogressive supranuclear palsyspinocerebellar ataxia

Identifiers

PMID27414076
PMCPMC7336900
OpenAlexW2460556022

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.